Platelet-derived growth factor (PDGF) is known to have regulatory control of a large number of cellular components, including various receptors. We show that muscarinic acetylcholine receptors of the m2 subtype on CCL 137 human fibroblasts in culture are affected by PDGF treatment. A time-dependent down-regulation is observed in steady-state RNA levels, followed by a decrease in ligand-binding capacity. Minimum RNA levels are attained at 11 h; minimum binding capacity is observed after 24 h of treatment. To our knowledge, this is the first example of negative gene control by PDGF.
INTRODUCTION
Muscarinic cholinergic receptors modulate physiological responses such as smooth-muscle contraction, vasodilatation, glandular secretion and neural transmission, and are widely distributed in tissues. Subtypes ofmuscarinic receptors, originally delineated by specific ligand-binding patterns, have more recently been further distinguished by their gene sequences (Kubo et al., 1986; Braun et al., 1987; Gocayne et al., 1987; Peralta et al., 1987a,b; Bonner et al., 1988) . The genetically defined subtypes ml-m5 have been localized to different areas of brain, and m3 is also expressed in exocrine secretory glands; subtype m2 corresponds to the pharmacologically defined M2 receptors in cardiac and vascular tissues (Bonner et al., 1987; Peralta et al., 1987a; Maeda et al., 1988) . Differences in inhibition of adenylate cyclase, activation of the phosphatidylinositol cycle and interactions with G-proteins also distinguish several of the muscarinic-receptor subtypes (Ashkenazi et al., 1987; Kerlavage et al., 1987; Peralta et al., 1988; Stein et al., 1988) .
A human embryonic lung fibroblast line, CCL 137, displaying abundant muscarinic receptors, has been previously described by our laboratory, and the receptors have been pharmacologically characterized as belonging to the M2 subtype (Andre et al., 1988) . These receptors mediate inhibition of adenylate cyclase and, with less efficiency, stimulation of phosphatidylinositol hydrolysis.
Platelet-derived growth factor (PDGF) is a known growth factor for fibroblasts. Among its multiple effects are autoregulation of PDGF receptors (Heldin et al., 1982) and transmodulation of a variety of membrane receptors such as those for 5-hydroxytryptamine (Coughlin et al., 1981) , lowdensity lipoprotein (Habenicht et al., 1986) , transferrin (Davis & Czech, 1986) , interleukin 1 (Bonin & Singh, 1988) and epidermal growth factor (Wharton et al., 1982; Olashaw et al., 1986) . The transcription of several genes is stimulated by PDGF (Cochran et al., 1983) .
In the present report, we have investigated whether m2 muscarinic receptors also come under the regulatory control of PDGF. We evaluated binding of the cholinergic antagonist quinuclidinyl [phenyl-4-3H] We show that PDGF induces a time-dependent decrease in muscarinic-receptor number in confluent growth-arrested cells, without altering binding affinity of the receptors. Decreased muscarinic-ligand binding was preceded by a decrease in the steady-state level of RNA for the m2 subtype of muscarinic receptor. These results indicate that PDGF does participate in the regulation of a muscarinic receptor.
METHODS

Cell culture
The human lung fibroblast line CCL 137 (HEL 299) was obtained from the American Type Culture Collection. The cells were cultured as previously described (Andre et al., 1988) . At 1 day after confluence was reached, the medium was replaced with fresh medium supplemented with 1 % (v/v) fetal-calf serum. Under these conditions, the cells became quiescent after 24 h, as measured by [3H] thymidine incorporation and by cell counts. We determined that the number of muscarinic binding sites was decreased by 40-50 % in cells maintained for 48 h in medium containing 1 % fetal-calf serum, compared with cells kept in medium with 10 % fetal-calf serum. Experiments were all conducted with cell cultures maintained in medium containing 1 % fetal-calf serum, designated 'serum-starved cultures'.
Stimulation
During the 48 h of serum starvation, CCL 137 fibroblasts were exposed to recombinant PDGF (B-chain; Amersham), at 4 ng/ml of culture medium, or to an equivalent volume of vehicle (0.1 M-acetic acid containing 0.5% BSA) for periods of Binding declined in a time-dependent manner in PDGF-treated cells (Fig. 1) (Fig. 3a) and did not express detectable ml receptors, (results not shown). After addition of PDGF to the cell cultures, a decrease in m2-receptor mRNA levels was observed after 5 and 9 h. In contrast, actin RNA levels did not change (Fig. 3b) .
Autoradiographs of slot-blots from two independent experiments were quantified by densitometric scanning. The time course of the change in m2-receptor mRNA levels was compared with that of [3H]QNB binding (Fig. 4) (Adem et al., 1987) .
Some previous reports indicate that muscarinic agonists alter DNA synthesis either positively (Ashkenazi et al., 1989a,b) or negatively (Conklin et al., 1988) . The physiological role of PDGF-induced down-regulation of m2 muscarinic receptors may be related to an involvement of these in cell proliferation. To our knowledge, this is the first example of negative control of RNA levels by PDGF. 
